The global PEGylated proteins market is expected to witness significant
demand over the forecast period. PEGylated proteins come in handy in
augmenting drug potency by its half-life and offer a convenient cover from
protein enzymatic degradation. Profound spending on the part of pharmaceutical
and biotechnology companies in R&D investments, growth in biologics sector
and incessant spread of lifestyle diseases is a market driver to PEGylated
protein market. Restraints observed in PEGylated proteins market include
unresponsiveness and frugality of observed market coupled with product-recall.
Increasing market for protein-based drugs over non-protein
drugs is driver to growth of PEGylated proteins market. Segmentation of
PEGylated proteins market by product includes consumables, PEGylation kits and
services. Segmentation of PEGylated proteins market by protein type constitute
colony stimulating factors, interferons, erythropeitin, mAbs, recombinant
factor VIII and other protein type.
By application, PEGylated proteins industry comprises cancer
treatment, hepatitis, chronic kidney diseases, hemophilia, multiple sclerosis,
gastrointestinal disorders and other applications. By end-user, markets
comprise pharmaceutical and biotechnology companies, CRO’s and academic
research institutes. By geography, market size comprises North America, Europe,
Asia pacific, MEA and Latin America. Consumable product segment accounted for
large share in market revenue in PEGylated proteins industry. Growth in
PEGylated proteins market is attributed to marked adoption of monoclonal antibodies,
erythropoietin and interferon for treatment of chronic diseases and large-scale
funding by government and grants for research.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/pegylated-proteins-market
As per news, big growth in PEGylated proteins industry is
projected owing to growing government favors and collaborations between foreign
bodies and local players in the region. Asia Pacific has turned into a
favorable market for many big biopharma players who are setting base in Asia
pacific markets with investments on a large scale in R&D wing. New reagents
such as biodegradable polymers, PEG linkers offer a huge market by providing
impetus in ongoing research of drug delivery technology due to capability in
providing a biomaterial having amphiphillic properties.
Increasing applications of PEGylated proteins in treating
cancer, blood disorder, and chronic disease are prominent factors in PEGylated
proteins market. Increasing application of new products including PEGylation
reagents and kits is an area of focus in many emerging countries. North America
exhibited maximum growth in PEGylated protein industry with Asia pacific
constituting emerging market for PEGylated proteins industry.
As per news,
PEGylation is a drug delivery technique that displays association of
polyethylene glycol chains (PEG) to a therapeutic protein, peptide or
non-peptide molecule. PEG reagents form covalent bonds to find application in
oncology, blood disorders, chronic and auto immune diseases and chronic
diseases. Key players include Merck Millipore, Thermo Fischer Scientific, NOF
Corporation, JenKem Technology, Creative PEGworks, Celares GmbH, Quanta
Biodesign, Biomatrik, Inc., Iris Biotech GmbH, Laysan Bio, Ltd.
Request Sample Copy of this Market
Research @ https://www.millioninsights.com/industry-reports/pegylated-proteins-market/request-sample
Comments
Post a Comment